Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes

Archive ouverte

Bigot, Pierre | Hétet, Jean-François | Bernhard, Jean-Christophe | Fardoun, Tarek | Audenet, François | Xylinas, Evanguelos | Ploussard, Guillaume | Pignot, Géraldine | Bessede, Thomas | Ouzaid, Idir | Robine, Edouard | Brureau, Laurent | Treigny, Olivier, Merigot De | Maurin, Charlotte | Long, Jean-Alexandre | Rouffilange, Jean | Hoarau, Nicolas | Lebdai, Souhil | Rouprêt, Morgan | Bastien, Laurence | Neuzillet, Yann | Mongiat-Artus, Pierre | Verhoest, Grégory | Zerbib, Marc | Ravery, Vincent | Rigaud, Jérôme | Bellec, Laurent | Baumert, Hervé | Chautard, Denis | Bensalah, Karim | Escudier, Bernard | Paparel, Philippe | Grenier, Nicolas | Rioux-Leclercq, Nathalie | Azzouzi, Abdel-Rahmène | Soulié, Michel | Patard, Jean-Jacques

Edité par CCSD ; Elsevier -

International audience. BACKGROUND: The purpose of this study was to evaluate morbidity, functional, and oncological outcomes after NSS in renal tumors \textgreater 7 cm. MATERIALS AND METHODS: We retrospectively analyzed data from 168 patients with tumors \textgreater 7 cm who were treated using NSS between 1998 and 2012. RESULTS: Imperative and elective indications accounted for 76 (45.2%) and 92 (54.8%) patients, respectively. Major perioperative complications and renal function deterioration occurred in 33 (19.6%) and 51 patients (30.4%), respectively. In multivariate analysis, age older than 60 years (P = .001; hazard ratio [HR], 5) and tumor malignancy (P = .014; HR, 6.7) were prognostic factors for renal function deterioration whereas imperative indication was a risk factor for major postoperative complications (P = .0019; HR, 2.7). In 126 (75%) patients with malignant tumors, after a median follow-up of 30 months (range, 1-254 months), 25 patients (20.2%) died. In multivariate analysis, imperative indication (P = .023; HR, 4.2), positive surgical margin (P = .021; HR, 3.3), and Fuhrman grade \textgreater II (P = .013; HR, 3.7) were prognostic indicators for cancer-free survival (CFS). Imperative indication (P = .04; HR, 8.5) and Fuhrman grade \textgreater II (P = .04; HR, 3.9) were predictive factors of cancer-specific survival (CSS). In case of elective indication, positive surgical margin, local recurrence, and cancer-related death occurred in 4 (7.6%), 1 (1.1%), and 1 (1.1%) cases, respectively. For elective indication, 5-year estimates of CFS, CSS, and overall survival rates were: 85.7%, 98%, and 93.9%, respectively. CONCLUSION: In this selected population, imperative vs. elective indication status seems to play a critical role in oncologic outcomes. Oncologic results for elective indications are close to those reported with radical nephrectomy.

Consulter en ligne

Suggestions

Du même auteur

Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?

Archive ouverte | Bigot, Pierre | CCSD

International audience. OBJECTIVE: To assess the effect of neoadjuvant targeted molecular therapies (TMTs) on size and level of inferior vena cava tumor thrombi and to evaluate their impact on surgical management. M...

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

Archive ouverte | Neuzillet, Yann | CCSD

International audience. BACKGROUND: Patients with end-stage renal disease (ESRD) are at risk of developing renal tumours. OBJECTIVE: Compare clinical, pathologic, and outcome features of renal cell carcinomas (RCCs)...

Safety and feasibility of laparoscopic nephrectomy for big tumors (10 cm): a retrospective multicentric study

Archive ouverte | Verhoest, Grégory | CCSD

International audience. Objective - Evaluate the feasibility of laparoscopic nephrectomy for big tumors. Material and methods - Data from 116 patients were retrospectively collected from 16 tertiary centres. Clinic...

Chargement des enrichissements...